๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases

โœ Scribed by J. Bayry; M. Thirion; N. Misra; N. Thorenoor; S. Delignat; S. Lacroix-Desmazes; B. Bellon; S. Kaveri; M.D. Kazatchkine

Publisher
Springer Milan
Year
2003
Tongue
English
Weight
44 KB
Volume
24
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

High dose intravenous immunoglobulin tre
High dose intravenous immunoglobulin treatment: Mechanisms of action
โœ Peter Boros; Gabriel Gondolesi; Jonathan S. Bromberg ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 121 KB

Intravenous immunoglobulin (IVIg) treatment was introduced as replacement therapy for patients with antibody deficiencies, but evidence suggests that a wide range of immune-mediated conditions could benefit from IVIg. The immunoglobulins are precipitated from human plasma by fractionation methods. I

Intravenous immunoglobulin in the treatm
Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelines
โœ Marinos C. Dalakas ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 279 KB ๐Ÿ‘ 2 views

This review summarizes the current status of intravenous immunoglobulin (IVIg) in the treatment of autoimmune neuromuscular disorders and the possible mechanisms of action of the drug based on work in vivo, in vitro, and in animal models. Supply of idiotypic antibodies, suppression of antibody produ